NCT04366947

Intravascular Access in Suspected/Confirmed COVID-19 Patient

Comparison of Intraosseous Versus Intravenous Access in Suspected/Confirmed COVID-19 Patient in Prehospital Setting

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Lazarski University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The current COVID-19 pandemic, this is especially since the transmission of SARS-CoV-2 is thought to occur mainly through respiratory droplets generated by coughing and sneezing, by direct contact with contaminated surfaces and because in a large number of patients COVID-19 disease may be asymptomatic. As recommended by the CDC medical personnel should be equipped with full personal protective equipment (PPE) for AGP in contact with suspected/confirmed COVID-19 patient. Therefore, it is reasonable to search for the most effective methods of intravascular access in those conditions.

Conditions

• Emergency Medicine
• Cardiopulmonary Arrest
• Shock

Interventions

Type	Name	Description
DEVICE	NIO® (Intraosseous access)	obtaining intravascular access using a ready intravenous NIO needle set
DEVICE	Standard of Care (Intravenous access)	obtaining intravascular access using a standard intravenous cannula

Timeline

• Start date: 2020-04-14
• Primary completion: 2020-09-20
• Completion: 2020-10-30
• First posted: 2020-04-29
• Last updated: 2020-12-19

Locations

1 site across 1 country: Poland